Economic outcomes associated with an investigational drug service within a Veterans Affairs health care system.

ABSTRACT:

Background

An investigational drug service (IDS) has a foundational role in ensuring the safe and efficient management of investigational drugs. The objective of this assessment is to determine economic value of an IDS within a Veterans Affairs health care system.

Methods

This assessment was a single-center retrospective record review. Study protocols managed by the IDS over a 2-year period were evaluated for cost avoidance, revenue, and waived revenue. Cost avoidance was defined as the cost savings generated when a research subject received sponsor-provided treatment in place of a therapy that would have been otherwise funded by the institution. Revenue from fees charged to investigators and waived revenue based on the standardized IDS fee schedule were also totaled. The to

SUBMITTER: Brown JN 

PROVIDER: S-EPMC6461586 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature